Ethylestrenol
Star0
Identification
- Generic Name
- Ethylestrenol
- DrugBank Accession Number
- DB01493
- Background
An anabolic steroid with some progestational activity and little androgenic effect. [PubChem]
- Type
- Small Molecule
- Groups
- Withdrawn
- Structure
- Weight
- Average: 288.4675
Monoisotopic: 288.245315646 - Chemical Formula
- C20H32O
- Synonyms
- Ethylestrenol
- etilestrenol
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- ATC Codes
- A14AB02 — Ethylestrenol
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as pregnane steroids. These are steroids with a structure based on the 21-carbon pregnane skeleton.
- Kingdom
- Organic compounds
- Super Class
- Lipids and lipid-like molecules
- Class
- Steroids and steroid derivatives
- Sub Class
- Pregnane steroids
- Direct Parent
- Pregnane steroids
- Alternative Parents
- 17-hydroxysteroids / Delta-4-steroids / Tertiary alcohols / Cyclic alcohols and derivatives / Hydrocarbon derivatives
- Substituents
- 17-hydroxysteroid / Alcohol / Aliphatic homopolycyclic compound / Cyclic alcohol / Delta-4-steroid / Hydrocarbon derivative / Hydroxysteroid / Organic oxygen compound / Organooxygen compound / Pregnane-skeleton
- Molecular Framework
- Aliphatic homopolycyclic compounds
- External Descriptors
- tertiary alcohol, 17beta-hydroxy steroid (CHEBI:31578)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- ADC79EK5Q8
- CAS number
- 965-90-2
- InChI Key
- AOXRBFRFYPMWLR-XGXHKTLJSA-N
- InChI
- InChI=1S/C20H32O/c1-3-20(21)13-11-18-17-9-8-14-6-4-5-7-15(14)16(17)10-12-19(18,20)2/h6,15-18,21H,3-5,7-13H2,1-2H3/t15-,16+,17+,18-,19-,20-/m0/s1
- IUPAC Name
- (1S,3aS,3bR,9aR,9bS,11aS)-1-ethyl-11a-methyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-ol
- SMILES
- [H][C@@]12CC[C@@](O)(CC)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCCC=C3CC[C@@]21[H]
References
- Synthesis Reference
Szpilfogel, S.A. and de Winter, M.S.; U.S. Patent 2,878,267; March 17, 1959; assigned to Organon Inc. Szpilfogel, S.A., Hanegraaf, J.A. and van Dijck, L.A.; U.S. Patent 3,112,328; Nov. 26, 1963 assigned to Organon Inc.
- General References
- Not Available
- External Links
- PubChem Compound
- 13765
- PubChem Substance
- 46505460
- ChemSpider
- 13168
- 4162
- ChEBI
- 31578
- ChEMBL
- CHEMBL1200623
- ZINC
- ZINC000004215863
- PharmGKB
- PA449539
- Wikipedia
- Ethylestrenol
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
Property Value Source melting point (°C) about 50 Szpilfogel, S.A. and de Winter, M.S.; U.S. Patent 2,878,267; March 17, 1959; assigned to Organon Inc. Szpilfogel, S.A., Hanegraaf, J.A. and van Dijck, L.A.; U.S. Patent 3,112,328; Nov. 26, 1963 assigned to Organon Inc. - Predicted Properties
Property Value Source Water Solubility 0.00086 mg/mL ALOGPS logP 5.2 ALOGPS logP 4.69 Chemaxon logS -5.5 ALOGPS pKa (Strongest Basic) -0.27 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 1 Chemaxon Hydrogen Donor Count 1 Chemaxon Polar Surface Area 20.23 Å2 Chemaxon Rotatable Bond Count 1 Chemaxon Refractivity 88.5 m3·mol-1 Chemaxon Polarizability 35.94 Å3 Chemaxon Number of Rings 4 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 1.0 Blood Brain Barrier + 0.9876 Caco-2 permeable + 0.8415 P-glycoprotein substrate Substrate 0.6943 P-glycoprotein inhibitor I Inhibitor 0.5427 P-glycoprotein inhibitor II Non-inhibitor 0.8205 Renal organic cation transporter Non-inhibitor 0.7538 CYP450 2C9 substrate Non-substrate 0.8322 CYP450 2D6 substrate Non-substrate 0.9092 CYP450 3A4 substrate Substrate 0.7296 CYP450 1A2 substrate Non-inhibitor 0.8767 CYP450 2C9 inhibitor Non-inhibitor 0.8723 CYP450 2D6 inhibitor Non-inhibitor 0.9163 CYP450 2C19 inhibitor Non-inhibitor 0.6126 CYP450 3A4 inhibitor Non-inhibitor 0.7518 CYP450 inhibitory promiscuity High CYP Inhibitory Promiscuity 0.5395 Ames test Non AMES toxic 0.9436 Carcinogenicity Non-carcinogens 0.9323 Biodegradation Not ready biodegradable 0.9786 Rat acute toxicity 1.8534 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.7664 hERG inhibition (predictor II) Non-inhibitor 0.6561
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-00dr-0090000000-2d93d93f373f853a6ee3 Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-000i-0090000000-e5efc571d7156bf39d14 Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-000i-0090000000-2d634fad3c234309de53 Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-00di-1290000000-48e9e92f08dfda7dd724 Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-000i-0090000000-fe912bbb2856f356a99d Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-0002-9600000000-223ec03bc30d2c0474ed Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 179.3057716 predictedDarkChem Lite v0.1.0 [M-H]- 174.30498 predictedDeepCCS 1.0 (2019) [M+H]+ 179.6054716 predictedDarkChem Lite v0.1.0 [M+H]+ 176.70055 predictedDeepCCS 1.0 (2019) [M+Na]+ 179.2808716 predictedDarkChem Lite v0.1.0 [M+Na]+ 183.25311 predictedDeepCCS 1.0 (2019)
Drug created at July 31, 2007 13:09 / Updated at February 21, 2021 18:51